Developing immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology.

Melanoma
Pre-ClinicalPhase 1Phase 2
Head & Neck Squamous Cell Carcinoma
Pre-ClinicalPhase 1Phase 2
Lung Cancer
Pre-ClinicalPhase 1
Phase
Asthma
Pre-ClinicalPhase 1Phase 2